NO20090579L - Controls with controlled pharmacokinetics - Google Patents

Controls with controlled pharmacokinetics

Info

Publication number
NO20090579L
NO20090579L NO20090579A NO20090579A NO20090579L NO 20090579 L NO20090579 L NO 20090579L NO 20090579 A NO20090579 A NO 20090579A NO 20090579 A NO20090579 A NO 20090579A NO 20090579 L NO20090579 L NO 20090579L
Authority
NO
Norway
Prior art keywords
binder
effect
controls
food effect
food
Prior art date
Application number
NO20090579A
Other languages
Norwegian (no)
Inventor
Ilan Zalit
Anat Sofer-Raz
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20090579L publication Critical patent/NO20090579L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen angår fremgangsmåter for å redusere matens påvirkning på et legemiddel som viser slik matvirkning, ved å fremstille en formulering som omfatter et slikt legemiddel og minst ett bionedbrytbart bindemiddel eller lipofilt bindemiddel. Oppfinnelsen angår også en fremgangsmåte for fremstilling av en formulering som har en målrettet matpåvirkning, omfattende (a) å bestemme en målrettet matpåvirkning, og (b) en aktiv farmasøytisk ingrediens som viser matpåvirkning kombineres med en tilstrekkelig mengde av (i) minst ett bionedbrytbart bindemiddel, (ii) minst ett lipofilt bindemiddel, eller (iii) kombinasjoner derav.BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to methods of reducing the effect of food on a drug showing such food effect, by preparing a formulation comprising such a drug and at least one biodegradable binder or lipophilic binder. The invention also relates to a method for preparing a formulation having a targeted food effect, comprising (a) determining a targeted food effect, and (b) combining an active pharmaceutical ingredient showing food effect with a sufficient amount of (i) at least one biodegradable binder. , (ii) at least one lipophilic binder, or (iii) combinations thereof.

NO20090579A 2006-07-06 2009-02-05 Controls with controlled pharmacokinetics NO20090579L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81904106P 2006-07-06 2006-07-06
PCT/US2007/015593 WO2008005543A2 (en) 2006-07-06 2007-07-06 Compositions with controlled pharmacokinetics

Publications (1)

Publication Number Publication Date
NO20090579L true NO20090579L (en) 2009-02-05

Family

ID=38739986

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090579A NO20090579L (en) 2006-07-06 2009-02-05 Controls with controlled pharmacokinetics

Country Status (9)

Country Link
EP (1) EP2037894A2 (en)
JP (1) JP2009542693A (en)
KR (1) KR20090017668A (en)
CN (1) CN101484144A (en)
CA (1) CA2654529A1 (en)
IL (1) IL195542A0 (en)
MX (1) MX2008016573A (en)
NO (1) NO20090579L (en)
WO (1) WO2008005543A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2306982T3 (en) * 2008-06-27 2015-04-20 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical compositions of rosuvastatin calcium
US8977133B2 (en) 2012-05-31 2015-03-10 Corning Optical Communications LLC Distributed communications system employing free-space-optical link(S), and related components and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1414496B1 (en) * 2001-08-07 2010-10-20 Galephar M/F Pharmaceutical composition containing a combinaition of ppar-alpha, pravastatin and polyglycolized glyceride
US6669955B2 (en) * 2001-08-28 2003-12-30 Longwood Pharmaceutical Research, Inc. Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
EP1680086A2 (en) * 2003-10-10 2006-07-19 LifeCycle Pharma A/S A solid dosage form comprising a fibrate and a statin
ES2255426B1 (en) * 2004-10-19 2007-08-16 Gp Pharm, S.A. PHARMACEUTICAL FORMULATION THAT INCLUDES MICROCAPSULES OF STATINS SUSPENDED IN ESTER ALKYLS OF POLYINSATURATED FATTY ACIDS (PUFA).

Also Published As

Publication number Publication date
MX2008016573A (en) 2009-01-28
EP2037894A2 (en) 2009-03-25
JP2009542693A (en) 2009-12-03
CN101484144A (en) 2009-07-15
CA2654529A1 (en) 2008-01-10
KR20090017668A (en) 2009-02-18
WO2008005543A2 (en) 2008-01-10
WO2008005543A3 (en) 2008-02-14
IL195542A0 (en) 2009-09-01

Similar Documents

Publication Publication Date Title
CR11074A (en) SYNERGISTIC COMPOSITIONS FOR PEST CONTROL
CR20110110A (en) PHARMACEUTICAL COMPOSITION
CY1118099T1 (en) ACETIC OLYPRISTAL TABLES
NO20071667L (en) A pharmaceutical composition comprising levetiracetam and a process for the preparation of the composition
CY1119488T1 (en) BASES FOR TREATMENT Ή / AND PREVENTION OF SLEEP DISORDER
BRPI0720972B8 (en) cyclopamine analog compounds and pharmaceutical compositions comprising said compounds
NO20090797L (en) Pharmaceutical compositions comprising candesartan cilexetil
NO20075660L (en) Composition for the treatment of inflammatory diseases
NO20080284L (en) Cannabionoid active pharmaceutical ingredient for improved dosage forms
TN2009000180A1 (en) NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF
NO20083104L (en) Solid preparation
WO2015017813A3 (en) Inhibitors of the farnesoid x receptor and uses in medicine
MX338895B (en) Stabilized oil-in-water emulsions including agriculturally active ingredients.
WO2009147170A3 (en) Drug combinations comprising a dgat inhibitor and a ppar-agonist
FR2983409B1 (en) COMPRESSOR CAPABLE OF COMBATTING INJECTION MISTAKE
ES2376043T3 (en) INDAZOL DERIVATIVES FOR THE TREATMENT OF DISEASES INDUCED BY HSP90.
NO20080220L (en) Formulations with high drug loading and dosage forms
RS53759B1 (en) Fungicidal composition and method for controlling plant diseases
EA200800698A1 (en) METHOD FOR STABILIZATION OF PHARMACEUTICAL FORMS FOR INTRODUCTION INCLUDING MICROORANISM
NO20083836L (en) N hydroksyakrylamidforbindelser
MX2012006921A (en) Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles.
WO2008004132A3 (en) The vapor-phase application of spinosyn for the control of pests, and formulations and products utilizing the same
NO20092763L (en) Isosorbide mononitrate derivatives for the treatment of intestinal disorders
NO20090579L (en) Controls with controlled pharmacokinetics
EA201070448A1 (en) NEW COMPOSITIONS ON THE BASIS OF TAXOIDS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application